Moulin F, Haut J
J Fr Ophtalmol. 1983;6(8-9):661-70.
One hundred phakic eyes of 76 patients with primary open angle glaucoma received argon laser therapy to the trabecular meshwork, a method, based on the works of James Wise, which we prefer to call trabecular retraction for two reasons: 1) the mechanical factor of trabecular tightening caused by the laser microscars and 2) to differentiate it from initial argon laser treatment in primary open angle glaucoma: trabeculopuncture. Argon laser trabecular retraction involves application to the entire pigmentary trabecular ring, just anterior to the scleral spur, of 100 evenly spaced non-penetrating burns, using a 50 microM. beam diameter with a pulse duration of 0,1 sec, and a power level adjusted to produce a minimum visible trabecular reaction. Laser treatment was performed on an out-patient basis using a three mirror Goldmann lens after topical anesthesia. Pre-laser anti-glaucoma medical treatment was continued unchanged during the follow-up period of this study, to assess accurately the effect of the laser treatment on intraocular pressure (IOP) without introducing the variable of changing medications. Treatment was applied to eyes with uncontrolled glaucoma on maximum tolerable medical therapy and, as such, candidates for surgery, eyes of patients unable to tolerate side effects of effective intensive medical therapy, and eyes with controlled open angle glaucoma to permit reduction of medical therapy. Mean pressure drop in the 100 eyes was 8,9 mmHg, the reduction of IOP being achieved between 3 and 6 weeks after the laser procedure. Surgery for glaucoma was avoided in 93% of the eyes. Pressure drop in 75% of treated eyes was between 4 and 11 mmHg, in 16% was 12 mmHg or more, and in 9% was 3 mmHg or less. Follow-up was for at least three months and in some cases extended to 15 months. These results and data from published reports suggest that the pressure drop obtained three months post-laser could be considered definitive, except in a very small percentage of eyes. Average intraocular pressure reduction in patients under 60 years was 8,3 mmHg and 88% of the eyes had a drop in IOP of 4 mmHg or more. In patients over 60 years, average intraocular pressure reduction was 9,3 mmHg and 93% of the eyes had a drop in IOP of 4 mmHg or more. The major complication in eyes with marked glaucomatous damage to their optic nerves is a possible rise in intraocular pressure following treatment. This post-laser increase in IOP was noted in 19 eyes but resolved either spontaneously or easily with medication. No visual field loss was observed in these eyes. Localized peripheral anterior synechiae were noted in 42 eyes, but these did not affect the success of the procedure.4
76例原发性开角型青光眼患者的100只屈光间质完整的眼睛接受了小梁网氩激光治疗。该方法基于詹姆斯·怀斯的研究成果,我们更倾向于称之为小梁牵拉术,原因有二:1)激光微瘢痕导致小梁收紧的机械因素;2)将其与原发性开角型青光眼最初的氩激光治疗——小梁穿刺术相区分。氩激光小梁牵拉术是指使用50微米的光束直径、0.1秒的脉冲持续时间以及调整至产生最小可见小梁反应的功率水平,在巩膜突前方的整个色素性小梁环上均匀间隔地进行100次非穿透性烧灼。激光治疗在局部麻醉后使用三面镜戈德曼透镜在门诊进行。在本研究的随访期间,术前抗青光眼药物治疗维持不变,以便在不引入药物变化变量的情况下准确评估激光治疗对眼压(IOP)的影响。治疗应用于接受最大耐受药物治疗但眼压仍未控制的青光眼患者的眼睛,这类患者原本是手术的候选对象;也应用于无法耐受有效强化药物治疗副作用的患者的眼睛,以及眼压已得到控制的开角型青光眼患者的眼睛,以便减少药物治疗。100只眼睛的平均眼压下降了8.9毫米汞柱,眼压降低在激光治疗后3至6周内实现。93%的眼睛避免了青光眼手术。75%接受治疗的眼睛眼压下降在4至11毫米汞柱之间,16%的眼睛眼压下降12毫米汞柱或更多,9%的眼睛眼压下降3毫米汞柱或更少。随访至少三个月,在某些情况下延长至15个月。这些结果以及已发表报告中的数据表明,除了极少数眼睛外,激光治疗三个月后获得的眼压下降可被视为确定的。60岁以下患者的平均眼压降低为8.3毫米汞柱,88%的眼睛眼压下降4毫米汞柱或更多。60岁以上患者的平均眼压降低为9.3毫米汞柱,93%的眼睛眼压下降4毫米汞柱或更多。视神经有明显青光眼性损害的眼睛的主要并发症是治疗后眼压可能升高。在19只眼睛中观察到了这种激光治疗后眼压升高的情况,但要么自行缓解,要么通过药物轻松解决。这些眼睛未观察到视野缺损。42只眼睛出现了局限性周边前粘连,但这些并未影响手术的成功率。